Battelle memorial institute (chem) - IDIQ for barda CRN animal model development
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 75A50122D00007
- Awardee
-
Battelle Memorial Institute UEI F125YU6SWK59
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Task orders
- 6 $25,765,925 obligated
Award facts
- Opportunity
-
- RFP75A50121R00012 Solicitation number
- Combined order value
-
- $25,771,436 Current, with exercised options
- $47,015,094 Potential, with all options
- Last date to order 100% complete
- IDV ceiling 38% used
- $67,500,000.00
- Maximum order
- $45,000,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Legislative mandates
-
- Clinger-Cohen Act FAR part 39
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded Battelle Memorial Institute a single-award Indefinite Delivery Contract valued at $67.5 million on July 28, 2022, for animal model development supporting the Biomedical Advanced Research and Development Authority's chemical research and network program. Under this contract, Battelle maintains nonclinical laboratory capabilities to conduct controlled exposures of animal species to chemical agents and establish models for evaluating medical countermeasures. The contract encompasses two qualification groups: Group A laboratories capable of conducting studies involving pulmonary threats and other chemicals, and Group B laboratories capable of working with Schedule 1 chemical threat agents including nerve and blister agents. All work is performed without set-aside designation under full and open competition, with the contract extending through July 31, 2026. Battelle's federal contracting expertise and established infrastructure for complex scientific testing position the contractor to deliver rigorous screening methodologies and animal model research that support the government's chemical defense and emergency preparedness objectives under the Project BioShield Act framework.
Through four delivery orders totaling approximately $42.8 million, ASPR has tasked Battelle with developing human-relevant animal models to evaluate medical countermeasures against chemical warfare agent exposure. Specific delivery orders address the establishment of rabbit models for long-term sulfur mustard-induced ocular injuries ($15.3 million, through September 2029, performed in Columbus, Ohio), development of small animal models for screening countermeasures against sulfur mustard inhalation injuries ($18.2 million, through August 2030, performed in Washington, DC), repurposing of chemical compounds panhematin and disulfiram as potential countermeasures against knockdown agents ($5.7 million, completed January 2025), and research on inhaled anti-muscarinic agents as contingency countermeasures against nerve agent-induced bronchorrhea ($3.6 million, completed September 2024, performed in Columbus, Ohio). All delivery orders utilize cost-plus-fixed-fee pricing and carry no set-aside designations, reflecting Battelle's competitive capabilities in full and open procurements with the federal government.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Original award | $75,000 |
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| Oregon Health & Science University | $79,297 | |
| Crosbys Drugs Inc. | $232,500 | |
| Hsrl Operating, LLC | $110,456 | |
| Edwards Lifesciences LLC | $170,700 | |
| Amplifybio LLC | $53,760 |
Quick answers
Who was awarded contract 75A50122D00007?
75A50122D00007 was awarded to Battelle Memorial Institute by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on July 28, 2022.
How much is contract 75A50122D00007 worth?
Orders under 75A50122D00007 have obligated $25,765,925. Their combined current value, with exercised options, is $25,771,436. Their combined potential value, with all options, is $47,015,094. 75A50122D00007's own ceiling is $67,500,000. A single order can be worth up to $45,000,000.
How many orders have been placed under contract 75A50122D00007?
6 orders have been placed under 75A50122D00007, the latest on July 16, 2026.
Who can order from contract 75A50122D00007?
75A50122D00007 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75A50122D00007 competed?
The extent of competition for 75A50122D00007 was full and open competition. The government received 5 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV